Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Sodium valproate: its use in primary psychiatric disorders.

Sodium valproate: its use in primary psychiatric disorders. Sodium valproate has been reported to be effective in the treatment of recurrent major affective and schizoaffective disorders. The records of 36 consecutive patients with various psychiatric diagnoses, who received valproate at our center, were retrospectively reviewed. None of these patients displayed a diagnosable neurologic disorder or paroxysmal EEG activity. Sixteen (44%) of the 36 patients experienced a moderate to marked response to valproate. The diagnoses of bipolar or schizoaffective disorder and the presence of nonparoxysmal EEG abnormalities both predicted a favorable response. The authors conclude that valproate deserves further study as a possible treatment for major affective disorder. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of clinical psychopharmacology Pubmed

Sodium valproate: its use in primary psychiatric disorders.

Journal of clinical psychopharmacology , Volume 7 (1): 9 – Apr 7, 1987

Sodium valproate: its use in primary psychiatric disorders.


Abstract

Sodium valproate has been reported to be effective in the treatment of recurrent major affective and schizoaffective disorders. The records of 36 consecutive patients with various psychiatric diagnoses, who received valproate at our center, were retrospectively reviewed. None of these patients displayed a diagnosable neurologic disorder or paroxysmal EEG activity. Sixteen (44%) of the 36 patients experienced a moderate to marked response to valproate. The diagnoses of bipolar or schizoaffective disorder and the presence of nonparoxysmal EEG abnormalities both predicted a favorable response. The authors conclude that valproate deserves further study as a possible treatment for major affective disorder.

Loading next page...
 
/lp/pubmed/sodium-valproate-its-use-in-primary-psychiatric-disorders-QenbJooJIJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0271-0749
pmid
3102563

Abstract

Sodium valproate has been reported to be effective in the treatment of recurrent major affective and schizoaffective disorders. The records of 36 consecutive patients with various psychiatric diagnoses, who received valproate at our center, were retrospectively reviewed. None of these patients displayed a diagnosable neurologic disorder or paroxysmal EEG activity. Sixteen (44%) of the 36 patients experienced a moderate to marked response to valproate. The diagnoses of bipolar or schizoaffective disorder and the presence of nonparoxysmal EEG abnormalities both predicted a favorable response. The authors conclude that valproate deserves further study as a possible treatment for major affective disorder.

Journal

Journal of clinical psychopharmacologyPubmed

Published: Apr 7, 1987

There are no references for this article.